| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 15 Aug 24 | NBIX Neurocrine Biosciences | Common Stock | Sell | Dispose S | No | No | 146.69 | 14,250 | 2.09 mm | 37,491 |
| 7 Jun 24 | FATE Fate Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.68 | 40,000 | 147.20 k | 40,000 |
| 5 Jun 24 | DARE Daré Bioscience | Stock Option Common stock | Grant | Acquire A | No | No | 0.43 | 40,000 | 17.20 k | 40,000 |
| 22 May 24 | NBIX Neurocrine Biosciences | RSU Common Stock | Grant | Acquire A | No | No | 0 | 2,869 | 0.00 | 2,869 |
| 20 May 24 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | Yes | No | 2.01 | 60,000 | 120.60 k | 60,000 |
